Percutaneous Mitral Valve Therapy: The Next Decade
After more than a decade, the field of transcatheter mitral valve therapy is still in its infancy, yet it is surprisingly crowded. The first percutaneous mitral valve company was founded in 1999, the same year that the first transcatheter aortic valve implantation (TAVI) company was founded, but while TAVI is now on the market in Europe and in the US, the leading transcatheter mitral valve therapy has only just completed clinical trials.
You may also be interested in...
Device firms have already been active with M&A deals in 2014. Here are 10 companies to look for as potential acquisition targets going forward.
Edwards is betting on next-generation Sapien devices and efforts towards a transcatheter mitral valve, as Medtronic and other competitors move closer to threatening the firm’s TAVR leadership position.
You know times are tough for medtech start-ups in the US when even a successful serial entrepreneur like Michael Lesh, MD, is told by VCs, “We love your idea, but….” Middle Peak Medical, Lesh’s new start-up in the mitral valve space, solved its problem with a Series A financing round involving European investors and by co-locating itself in Germany and the US.